Has Jay Khambhati, MD received payments from drug or device companies?

Yes. Drug and device makers reported $31,332 in general payments to Jay Khambhati, MD across 198 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jay Khambhati, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jay Khambhati, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jay Khambhati, MD

Interventional Cardiology · Chicago, ILNPI 1427443712

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (48.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Medtronic at 49.1% of the total. Reporting peaked in 2023 at $18,232 and has fallen 70.1% since, to $5,458 in 2025.

$31,332in general payments, 2019–2025

Across 198 payments — averaging $158.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$15K
Abbott$7K
Edwards Lifesciences$5K
Philips North America LLC$2K
Inari Medical, Inc.$572
Boston Scientific$259
plus $1K from 13 others

$28,034in research payments, 2019–2025

Across 6 payments — averaging $4672.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$28K

What the payments were for

Consulting fees$1,2004%
Grants$15,25049%
Travel & lodging$7,88225%
Food & beverage$6,67921%
Education$3211%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	38	$15,379
Abbott	44	$7,247
Edwards Lifesciences	47	$4,622
Philips North America LLC	15	$1,847
Inari Medical, Inc.	16	$572
Boston Scientific	6	$259
Abiomed	7	$229
Stryker	9	$224
Shockwave Medical, Inc	2	$213
Cardiovascular Systems Inc.	2	$174
Astellas Pharma US Inc	2	$155
GE HealthCare	1	$100
Acist Medical Systems, Inc.	1	$81
Chiesi USA, Inc.	1	$79
Teleflex LLC	3	$51
Terumo Medical Corporation	1	$35
Cardiva Medical, Inc.	1	$23
Novo Nordisk	1	$22
Amgen	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COREVALVE EVOLUT R$14,420
NAVITOR$2,345
Ultreon$1,200
Edwards SAPIEN 3 Transcatheter Heart Valve$1,006
PASCAL$772
(9525) Intracardiac Und$687
Intracardiac Undivided$660
EVOQUE$631
FLOWTRIEVER CATHETER, S$402
MitraClip$314
(9520) IGT Devices Undivided$242
ONYX FRONTIER$164
Diamondback Coronary$159
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$149
CT THROMBECTOMY SYSTEM KIT$126
SAPIEN 3 Ultra RESILIA$117
Watchman$111
XIENCE SKYPOINT$111

How this compares

$31,332 in reported general payments places this provider in the 80th percentile of 303 interventional cardiology providers in Illinois.

See all interventional cardiology providers in Illinois →

Medicare billing

Part B allowed, 2024

$47,466

Medicare patients

283

Services billed

513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	26	$255
Atorvastatin Calcium	12	$78

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Chicago

Atman ShahChicago$788K
David StewartChicago$169K
Hussam SuradiChicago$97K
Anita AsgarChicago$85K
Daniel SchimmelChicago$79K
Ranya SweisChicago$62K
Charles DavidsonChicago$62K
Fareed Moses ColladoChicago$42K
James FlahertyChicago$38K
Ashvarya ManglaChicago$36K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →